Pharmacological Reviews xPharm- The Comprehensive Pharmacology Reference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     



0031-6997/05/5704-509-526$7.00
Pharmacol Rev 57:509-526, 2005

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kubo, Y.
Right arrow Articles by Vandenberg, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kubo, Y.
Right arrow Articles by Vandenberg, C. A.

IUPHAR Compendium of Voltage-Gated Ion Channels 2005

International Union of Pharmacology. LIV. Nomenclature and Molecular Relationships of Inwardly Rectifying Potassium Channels

Yoshihiro Kubo, John P. Adelman, David E. Clapham, Lily Y. Jan, Andreas Karschin, Yoshihisa Kurachi, Michel Lazdunski, Colin G. Nichols, Susumu Seino and Carol A. Vandenberg

Division of Biophysics and Neurobiology, Department of Molecular Physiology, National Institute for Physiological Sciences, Myodaiji, Okazaki, Aichi, Japan (Y.K.); Vollum Institute, Oregon Health Sciences University, Portland, Oregon (J.P.A.); Howard Hughes Medical Institute, Children's Hospital, Harvard Medical School, Boston, Massachusetts (D.E.C.); Howard Hughes Medical Institute, Department of Physiology and Biochemistry, University of California, San Francisco, San Francisco, California (L.Y.J.); Institute of Physiology, University of Würzburg, Würzburg, Germany (A.K.); Department of Pharmacology II, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan (Y.K.); Institut de Pharmacologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique-Unité Propre de Recherche 411,Valbonne, France (M.L.); Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri (C.G.N.); Division of Cellular and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Hyago, Japan (S.S.); and Department of Molecular, Cellular and Developmental Biology, Neuroscience Research Institute, University of California, Santa Barbara, Santa Barbara, California (C.A.V.)

Introduction
Introduction

Since the initial cDNA cloning of the first inward rectifiers Kir1.1 (ROMK1) and Kir2.1 (IRK1) in 1993, a succession of new members of this family have been identified, including the G protein-coupled Kir3 and the ATP-sensitive Kir6. These channels play an important physiological role in the function of many organs, including brain, heart, kidney, endocrine cells, ears, and retina. The phylogenic tree shown in Fig. 1 illustrates the relationships between the seven Kir subfamilies based on amino acid sequence alignments. No new members of this family have been identified since this tree appeared in the 2002 edition of The IUPHAR Compendium of Voltage-Gated Ion Channels, and it is unlikely that any other members remain to be discovered.



View larger version (25K):
[in this window]
[in a new window]
 
FIG. 1. Phylogenetic tree of Kir channels. Amino acid sequence alignments and phylogenetic analysis for the 15 known members of the human Kir family were generated as described in the legend for Fig. 1 of "LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassiuim Channels". No new channels have been added to this topology since it appeared in the earlier edition of this compendium. International Union of Pharmacology and HUGO Gene Nomenclature Committee names of the genes are shown together with their chromosomal localization.

 
In the Kir section of the 2002 edition, we cited a very limited number of original cDNA cloning papers (Kubo et al., 2002Go). The scope of these citations has been expanded herein so that inferences on the molecular architecture and functional and pharmacological aspects can be readily drawn. Some of the newer work cited in this article is outlined below. It is noteworthy that much of this work describes the identification of associating proteins and the link between particular Kir genes and human diseases. These kinds of findings are expected to continue to increase:

Although it is not discussed herein, among the most exciting recent developments are those involving X-ray crystal structure analysis, including studies describing the structure of the cytoplasmic region of Kir3.1 (Nishida and MacKinnon, 2002Go), the entire structure of the bacterial Kir1.1 channel (Kuo et al., 2003Go), and the cytoplasmic region of Kir2.1 (Pegan et al., 2005Go). These studies demonstrated that inward rectifier K+ channels have a long cytoplasmic pore and confirmed the significance of negatively charged amino acids on the wall of the cytoplasmic pore that have been known to play critical roles for inward rectification. They also provided structure-based clues for the regulation mechanisms of gating by ligands such as G proteins and phosphatidylinositol 4,5-bisphosphate. The information yielded by analysis of crystal structures is extremely valuable since it will enable more precise approaches to establishing structure-function relationships. Also noteworthy are published studies on the dynamic aspects of channel function using fluorescence resonance energy transfer analysis of fluorescent-labeled molecules (Riven et al., 2003Go). Knowledge of these dynamic aspects of Kir channel function may also be expected to expand in the near future.

A great deal of additional knowledge on Kir function, structure-function relationships, regulation of expression, and links with diseases has been accumulated. Since it is not possible to describe it in detail here, we refer the reader instead to several excellent recent reviews (Stanfield et al., 2002Go; Bichet et al., 2003Go; Lu, 2004Go). See Tables 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 for Kir1 through Kir7.1.


View this table:
[in this window]
[in a new window]
 
TABLE 1 Kir1.1 channels

 

View this table:
[in this window]
[in a new window]
 
TABLE 2 Kir2.1 channels

 

View this table:
[in this window]
[in a new window]
 
TABLE 3 Kir2.2 channels

 

View this table:
[in this window]
[in a new window]
 
TABLE 4 Kir2.3 channels

 

View this table:
[in this window]
[in a new window]
 
TABLE 5 Kir2.4 channels

 

View this table:
[in this window]
[in a new window]
 
TABLE 6 Kir3.1 channels

 

View this table:
[in this window]
[in a new window]
 
TABLE 7 Kir3.2 channels

 

View this table:
[in this window]
[in a new window]
 
TABLE 8 Kir3.3 channels

 

View this table:
[in this window]
[in a new window]
 
TABLE 9 Kir3.4 channels

 

View this table:
[in this window]
[in a new window]
 
TABLE 10 Kir4.1 channels

 

View this table:
[in this window]
[in a new window]
 
TABLE 11 Kir4.2 channels

 

View this table:
[in this window]
[in a new window]
 
TABLE 12 Kir5.1 channels

 

View this table:
[in this window]
[in a new window]
 
TABLE 13 Kir6.1 channels

 

View this table:
[in this window]
[in a new window]
 
TABLE 14 Kir6.2 channels

 

View this table:
[in this window]
[in a new window]
 
TABLE 15 Kir7.1 channels

 

Acknowledgements

We gratefully acknowledge the support of Drs. Atsushi Inanobe (Kurachi Lab), Wade Pearson (Nichols Lab), and Florian Lesage (Lazdunski Lab) and the contributions of Dr. Henry Lester (California Institute of Technology, Pasadena, CA) to the earlier edition of this compendium.

Address correspondence to: Dr. Yoshihiro Kubo, Division of Biophysics and Neurobiology, Department of Molecular Physiology, National Institute for Physiological Sciences, Nishigoh-naka 38, Myodaiji, Okazaki, Aichi 444-8585, Japan.

Footnotes

The authors serve as the Subcommittee on Kir channels of the Nomenclature Committee of the International Union of Pharmacology.

Article, publication date, and citation information can be found at http://pharmrev.aspetjournals.org.

doi:10.1124/pr.57.4.11.

References

Bichet D, Haass FA, and Jan LY (2003) Merging functional studies with structures of inward rectifier K+ channels. Nat Rev Neurosci 4: 957-967.[CrossRef][Medline]

Buono RJ, Lohoff FW, Sander T, Sperling MR, O'Connor MJ, Dlugos DJ, Ryan SG, den GT, Zhao H, Scattergood TM, et al. (2004) Association between variation in the human KCNJ10 potassium ion channel gene and seizure susceptibility. Epilepsy Res 58: 175-183.[Medline]

Connors NC, Adams ME, Froehner SC, and Kofuji P (2004) The potassium channel Kir4.1 associates with the dystrophin-glycoprotein complex via alpha-syntrophin in glia. J Biol Chem 279: 28387-28392.[Abstract/Free Full Text]

Ferraro TN, Golden GT, Smith GG, Martin JF, Lohoff FW, Gieringer TA, Zamboni D, Schwebel CL, Press DM, Kratzer SO, et al. (2004) Fine mapping of a seizure susceptibility locus on mouse chromosome 1: nomination of Kcnj10 as a causative gene. Mamm Genome 15: 239-251.[CrossRef][Medline]

Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, et al. (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350: 1838-1849; erratum in N Engl J Med 351:1470.[Abstract/Free Full Text]

Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y, Lazdunski M, Lester HA, Nichols CG, et al. (2002) Kir potassium channels, in The IUPHAR Compendium of Voltage-gated Ion Channels (Catterall WA, Chandy KG, and Gutman G eds) pp 153-172, IUPHAR Media, Leeds, UK.

Kuo A, Gulbis JM, Antcliff JF, Rahman T, Lowe ED, Zimmer J, Cuthbertson J, Ashcroft FM, Ezaki T, and Doyle DA (2003) Crystal structure of the potassium channel KirBac1.1 in the closed state. Science (Wash DC) 300: 1922-1926.[Abstract/Free Full Text]

Leonoudakis D, Conti LR, Anderson S, Radeke CM, McGuire LMM, Adams ME, Froehner SC, Yates JR 3rd, and Vandenberg CA (2004) Protein trafficking and anchoring complexes revealed by proteomic analysis of inward rectifier potassium channel (Kir2x)-associated proteins. J Biol Chem 279: 22331-22346.[Abstract/Free Full Text]

Lu Z (2004) Mechanism of rectification in inward rectifier K+ channels. Annu Rev Physiol 66: 103-129.[CrossRef][Medline]

Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H, and Seino S (2002) Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med 8: 466-472.[CrossRef][Medline]

Nishida M and MacKinnon R (2002) Structural basis of inward rectification: cytoplasmic pore of the G-protein-gated inward rectifier GIRK1 at 1.8 A resolution. Cell 111: 957-965.[CrossRef][Medline]

Pegan S, Arrabit C, Zhou W, Kwiatkowski W, Collins A, Slesinger PA, and Choe S (2005) Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification. Nat Neurosci 8: 279-287.[CrossRef][Medline]

Riven I, Kalmanzon E, Segev L, and Reuveny E (2003) Conformational rearrangements associated with the gating of the G protein-coupled potassium channel revealed by FRET microscopy. Neuron 38: 225-235.[CrossRef][Medline]

Stanfield PR, Nakajima S, and Nakajima Y (2002) Constitutively active and G-protein coupled inward rectifier K+ channels: Kir2.0 and Kir3.0. Rev Physiol Biochem Pharmacol 145: 47-179.[Medline]

Yoo D, Flagg TP, Olsen O, Raghuram V, Foskett JK, and Welling PA (2004) Assembly and trafficking of a multiprotein ROMK (Kir 1.1) channel complex by PDZ interactions. J Biol Chem 279: 6863-6873.[Abstract/Free Full Text]

Wangemann P, Itza EM, Albrecht B, Wu T, Jabba SV, Maganti RJ, Lee JH, Everett LA, Wall SM, Royaux IE, et al. (2004) Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model. BMC Med 2: 30.[CrossRef][Medline]


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
D. Heitzmann and R. Warth
Physiology and Pathophysiology of Potassium Channels in Gastrointestinal Epithelia
Physiol Rev, July 1, 2008; 88(3): 1119 - 1182.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. M. Troncoso Brindeiro, R. W. Fallet, P. H. Lane, and P. K. Carmines
Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F171 - F178.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. A. Haass, M. Jonikas, P. Walter, J. S. Weissman, Y.-N. Jan, L. Y. Jan, and M. Schuldiner
Identification of yeast proteins necessary for cell-surface function of a potassium channel
PNAS, November 13, 2007; 104(46): 18079 - 18084.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
D. Heitzmann and R. Warth
No Potassium, No Acid: K+ Channels and Gastric Acid Secretion
Physiology, October 1, 2007; 22(5): 335 - 341.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. Cao, W. Lee-Kwon, K. Payne, A. Edwards, and T. L. Pallone
Descending vasa recta endothelia express inward rectifier potassium channels
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1248 - F1255.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Tikku, Y. Epshtein, H. Collins, A. J. Travis, G. H. Rothblat, and I. Levitan
Relationship between Kir2.1/Kir2.3 activity and their distributions between cholesterol-rich and cholesterol-poor membrane domains
Am J Physiol Cell Physiol, July 1, 2007; 293(1): C440 - C450.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Su, Y. Ohno, C. Lossin, H. Hibino, A. Inanobe, and Y. Kurachi
Inhibition of Astroglial Inwardly Rectifying Kir4.1 Channels by a Tricyclic Antidepressant, Nortriptyline
J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 573 - 580.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kubo, Y.
Right arrow Articles by Vandenberg, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kubo, Y.
Right arrow Articles by Vandenberg, C. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition
Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics